1. Home
  2. ATRC vs FPF Comparison

ATRC vs FPF Comparison

Compare ATRC & FPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATRC
  • FPF
  • Stock Information
  • Founded
  • ATRC 2000
  • FPF 2013
  • Country
  • ATRC United States
  • FPF United States
  • Employees
  • ATRC N/A
  • FPF N/A
  • Industry
  • ATRC Medical/Dental Instruments
  • FPF Trusts Except Educational Religious and Charitable
  • Sector
  • ATRC Health Care
  • FPF Finance
  • Exchange
  • ATRC Nasdaq
  • FPF Nasdaq
  • Market Cap
  • ATRC 1.1B
  • FPF 1.1B
  • IPO Year
  • ATRC 2005
  • FPF N/A
  • Fundamental
  • Price
  • ATRC $40.61
  • FPF $18.63
  • Analyst Decision
  • ATRC Strong Buy
  • FPF
  • Analyst Count
  • ATRC 9
  • FPF 0
  • Target Price
  • ATRC $43.00
  • FPF N/A
  • AVG Volume (30 Days)
  • ATRC 618.4K
  • FPF 186.7K
  • Earning Date
  • ATRC 02-12-2025
  • FPF 01-01-0001
  • Dividend Yield
  • ATRC N/A
  • FPF 8.08%
  • EPS Growth
  • ATRC N/A
  • FPF N/A
  • EPS
  • ATRC N/A
  • FPF N/A
  • Revenue
  • ATRC $447,573,000.00
  • FPF N/A
  • Revenue This Year
  • ATRC $18.02
  • FPF N/A
  • Revenue Next Year
  • ATRC $12.93
  • FPF N/A
  • P/E Ratio
  • ATRC N/A
  • FPF N/A
  • Revenue Growth
  • ATRC 17.56
  • FPF N/A
  • 52 Week Low
  • ATRC $18.94
  • FPF $13.91
  • 52 Week High
  • ATRC $43.11
  • FPF $18.09
  • Technical
  • Relative Strength Index (RSI)
  • ATRC 61.66
  • FPF 55.91
  • Support Level
  • ATRC $39.71
  • FPF $18.50
  • Resistance Level
  • ATRC $43.11
  • FPF $18.85
  • Average True Range (ATR)
  • ATRC 1.86
  • FPF 0.15
  • MACD
  • ATRC 0.15
  • FPF 0.02
  • Stochastic Oscillator
  • ATRC 63.10
  • FPF 45.00

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

About FPF First Trust Intermediate Duration Preferred & Income Fund of Beneficial Interest

First Trust Inter Dur Pref& Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek a high level of current income. Further, it has a secondary objective of capital appreciation. The Fund invests in the traditional preferred securities, hybrid preferred securities, floating rate & fixed-to-floating rate preferred securities, debt securities, convertible securities, and contingent convertible securities issued by U.S. and non-U.S. companies. Its investment portfolio includes industries such as Banks, Insurance, Capital Markets, Electric Utilities, Oil, Gas & Consumable Fuels, Food Products, and others.

Share on Social Networks: